Results of subtotal parathyroidectomy in hemodialysis patients

The American Journal of Medicine

Volumn 84, Issue 1, 1988, Pages 23-32

  Johnson, William J ^a   McCarthy, James T ^a   van Heerden, Jon A ^a   Sterioff, Sylvester ^a   Grant, Clive S ^a   Kao, Pai Chih ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PARATHYROIDECTOMY; SURGICAL TECHNIQUE;

ALUMINUM; BONE AND BONES; FEMALE; HUMAN; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; OSTEOMALACIA; PARATHYROID GLANDS; PARATHYROID HORMONES; RECURRENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 0023946385     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(88)90004-6     Document Type: Article

References (35)

1. Experience with a radio-immunoassay of parathyroid hormone in human sera
2. Hyperparathyroidism and renal failure
3. Azotaemic renal osteodystrophy: a quantitative study on iliac bone
4. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immuno-reactive parathyroid hormone
5. Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis
6. 1,25-dihydroxycholecalciferol effects in chronic dialysis: a double-blind controlled study
7. Osteomalacia after parathyroidectomy in patients with uremia
8. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure
9. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients
10. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum
11. Interpretation of serum aluminum values in dialysis patients
12. Gastrointestinal absorption of aluminum in chronic renal insufficiency
13. Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism
14. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis
15. Evaluation of image-diagnosing methods of enlarged parathyroid glands in chronic renal failure
16. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism: a one- to six-year follow-up
17. Treatment of secondary hyperparathyroidism in patients with chronic renal failure by total parathyroidectomy and parathyroid autograft
18. Clinical management of persistent and/or recurrent primary hyperparathyroidism
19. Transplantation of the parathyroid glands in man
20. Electrothermal atomic absorption spectrometric determination of aluminum in serum with a new technique for protein precipitation
21. Radioimmunoassay of human parathyroid hormone in serum
22. Development and validation of a new radioimmunoassay for parathyrin (PTH)
23. Outpatient percutaneous biopsy of the iliac crest
24. Skeletal remodeling and renal osteodystrophy
25. Elevated bone aluminum content in dialysis patients without osteomalacia
26. Histological quantitation of aluminum in iliac bone from patients with renal failure
27. Persistent severe hypercalcemia during maintenance hemodialysis
28. Therapy of aluminum overload (I.)
29. The efficacy of various treatment modalities on aluminum associated bone disease
30. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure
31. The natural course of dialysis osteomalacia
32. Pseudohyperparathyroidism
33. 1,25-dihydroxycholecalciferol effects in chronic dialysis
34. 3
35. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients